Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Neoprobe reports positive feedback from FDA for RIGScan development

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has completed a successful pre-IND meeting with the U.S. Food and Drug Administration on the development of RIGScan CR, the Company's proprietary radiopharmaceutical for the detection of colorectal cancer tumors.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

FDA's action impacts Elite pharma drugs

Elite Pharmaceuticals, Inc. advises that the US Food and Drug Administration announced that it intends to remove approximately 500 cough/cold and allergy related products from the U.S. market.

7 Mar 2011

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept for the use of magnetic particles for targeted cancer treatment, advanced sterilization techniques, an advanced imaging system, and an advanced microbolometer.

5 Mar 2011

Vanns Spices named winner of seventh annual Progressive Manufacturing 100 Awards

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that SYSPRO customer Vanns Spices Ltd., has been named a winner of the seventh annual Progressive Manufacturing 100 Awards, selected by Managing Automation Media, a Thomas Publishing Company, LLC publication.

5 Mar 2011

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

Cellular Dynamics International, the world's largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells under a feeder-free condition using chemically defined media.

5 Mar 2011

Bovie settles patent infringement ligation with Salient Surgical and Medtronic

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced a settlement to the June 10, 2010, action brought by Salient Surgical Technologies, Inc. and Medtronic, Inc. against the Company.

5 Mar 2011

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics in Oklahoma.

5 Mar 2011

Initial Microcutter surgical cutting, stapling device receives CE Mark certification

Cardica, Inc. today announced that an initial Microcutter surgical cutting and stapling device developed by Cardica has received CE Mark certification.

4 Mar 2011

Prism Medical revenues in fiscal 2010 is $66.6 million

Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2010. Revenues in fiscal 2010 were $66.6 million compared to $65.7 million in fiscal 2009.

4 Mar 2011

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo BioSciences, Inc. announced that data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and Opportunistic Infections, held in Boston from February 27 to March 2, 2011.

4 Mar 2011

SERS nanosubstrates revolutionize medical diagnostics

Gold-coated substrates of gallium nitride with specifically formed surface, developed by researchers from the Institute of Physical Chemistry of the Polish Academy of Sciences and the Institute of High Pressure Physics of the PAS display worldwide unique properties. Thanks to these new substrates, an extremely sensitive SERS analytical technique, capable of detecting even single molecules, after decades of waiting in specialized laboratories has finally got a chance to widespread and revolutionize medical diagnostics.

4 Mar 2011

New computer-controlled system to create cell assembly line

Borrowing a page from modern manufacturing, scientists from the Florida campus of The Scripps Research Institute have built a microscopic assembly line that mass produces synthetic cell-like compartments.

4 Mar 2011

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.

4 Mar 2011

FDA approves Amneal's Indomethacin ER capsules

Amneal Pharmaceuticals, LLC is pleased to announce that it received U.S. FDA approval for Indomethacin Extended Release capsules, USP in the 75 mg strength effective December 1, 2010.

3 Mar 2011

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Celerion, the premier provider of innovative early stage drug development solutions, announces the completion of a Clean Room and pharmacist certification to comply with USP 797 guidelines.

3 Mar 2011

FDA takes action against companies that manufacture unapproved prescription drugs

The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products. The affected products cannot be legally marketed in the United States.

3 Mar 2011

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.

3 Mar 2011

Manufacturing News and Research

Further Reading

Neoprobe reports positive feedback from FDA for RIGScan development

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

FDA's action impacts Elite pharma drugs

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

Vanns Spices named winner of seventh annual Progressive Manufacturing 100 Awards

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

Bovie settles patent infringement ligation with Salient Surgical and Medtronic

Grifols receives FDA approval for Alphanate to treat vCJD

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

Initial Microcutter surgical cutting, stapling device receives CE Mark certification

Prism Medical revenues in fiscal 2010 is $66.6 million

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

SERS nanosubstrates revolutionize medical diagnostics

New computer-controlled system to create cell assembly line

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

FDA approves Amneal's Indomethacin ER capsules

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

FDA takes action against companies that manufacture unapproved prescription drugs

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy